These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6622791)

  • 41. The effect of anticholinergic drugs on the inner eye muscles.
    Mehlfeld G; Bleichert A
    Graefes Arch Clin Exp Ophthalmol; 1986; 224(1):92-5. PubMed ID: 3943744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Studies on the interactions between digitalis glycosides, antibiotics and diuretics with the aid of radioimmunoassay].
    Chlewicka I
    Kardiol Pol; 1979; 22(6):611-21. PubMed ID: 529664
    [No Abstract]   [Full Text] [Related]  

  • 43. In vitro effect of hyoscine-N-butyl bromide and diclofenac sodium in human tuba uterina.
    Sengul M; Karadas B; Acar-Sahan S; Ozturk O; Yılmaz H; Simsek F; Kaya-Temiz T
    Basic Clin Pharmacol Toxicol; 2024 Aug; 135(2):173-179. PubMed ID: 38803141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical contribution to the study of hyoscine N-butylbromide (B 2011)].
    FORET J; SIMILON A
    J Belge Urol; 1952 Dec; 21(2):55-8. PubMed ID: 13044763
    [No Abstract]   [Full Text] [Related]  

  • 45. [Pharmacological and clinical observations on the combination of N-butyl-bromide of hyoscine and phenyldimethyl-pyrazolone-methylamino-methanesulfonate of sodium (buscopan compositum)].
    MARINO A; MURARO U
    Rass Int Clin Ter; 1959 Dec; 39():1333-56. PubMed ID: 14421164
    [No Abstract]   [Full Text] [Related]  

  • 46. Compatibility of haloperidol and hyoscine-N-butyl bromide in mixtures for subcutaneous infusion to cancer patients in palliative care.
    Barcia E; Reyes R; Luz Azuara M; Sánchez Y; Negro S
    Support Care Cancer; 2003 Feb; 11(2):107-13. PubMed ID: 12560939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyoscine butylbromide in labour.
    GARRETT AS; DRAPER VS
    Practitioner; 1963 May; 190():653-6. PubMed ID: 13960471
    [No Abstract]   [Full Text] [Related]  

  • 48. Morphine, haloperidol and hyoscine N-butyl bromide combined in s.c. infusion solutions: compatibility and stability. Evaluation in terminal oncology patients.
    Negro S; Reyes R; Azuara ML; Sánchez Y; Barcia E
    Int J Pharm; 2006 Jan; 307(2):278-84. PubMed ID: 16297583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Studies of the excretion of digoxin through urine in the human].
    Weiss D; Meyer-Elmen E; Ruiz-Torres A
    Verh Dtsch Ges Kreislaufforsch; 1968; 34():202-5. PubMed ID: 5736264
    [No Abstract]   [Full Text] [Related]  

  • 50. [Digoxin: biological availability and interactions].
    Halwa B
    Wiad Lek; 1981 Jan; 34(1):31-4. PubMed ID: 7023063
    [No Abstract]   [Full Text] [Related]  

  • 51. [The treatment of spastic states with hyoscine-N-butylbromide].
    HARTMANN HG
    Z Arztl Fortbild (Jena); 1953 Aug; 47(15):541-3. PubMed ID: 13090960
    [No Abstract]   [Full Text] [Related]  

  • 52. Lack of difference in digoxin urinary excretion with two intravenous infusion rates.
    Lindenbaum J; Long R; Wenger T; Mallis G; Cato A
    Clin Pharmacol Ther; 1981 Sep; 30(3):317-20. PubMed ID: 7273595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pharmacokinetic principles of dosage in digitalis administration: a study on human subjects].
    Blankart R; Preisig R
    Schweiz Med Wochenschr; 1970 Dec; 100(50):2163-4. PubMed ID: 5526156
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical consequences of pharmacokinetic properties of cardiac glycosides.
    Kochsiek K
    Eur Heart J; 1982 Dec; 3 Suppl D():79-86. PubMed ID: 6761130
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of hyoscine N-butylbromide on gastroesophageal reflux in normal subjects and patients with gastroesophageal reflux disease.
    Ciccaglione AF; Grossi L; Cappello G; Malatesta MG; Ferri A; Toracchio S; Marzio L
    Am J Gastroenterol; 2001 Aug; 96(8):2306-11. PubMed ID: 11519531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug interactions with digoxin.
    Brown DD; Spector R; Juhl RP
    Drugs; 1980 Sep; 20(3):198-206. PubMed ID: 7428668
    [No Abstract]   [Full Text] [Related]  

  • 57. [Various aspects of digoxin treatment].
    Preibisz J; Grzesiuk W
    Pol Arch Med Wewn; 1980 Apr; 63(4):411-6. PubMed ID: 6997836
    [No Abstract]   [Full Text] [Related]  

  • 58. Induction of rat intestinal P-glycoprotein by spironolactone and its effect on absorption of orally administered digoxin.
    Ghanem CI; Gómez PC; Arana MC; Perassolo M; Delli Carpini G; Luquita MG; Veggi LM; Catania VA; Bengochea LA; Mottino AD
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1146-52. PubMed ID: 16740618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Various opinions with regard to digoxin treatment].
    Halawa B
    Wiad Lek; 1982 Dec; 35(23-24):1545-53. PubMed ID: 6762762
    [No Abstract]   [Full Text] [Related]  

  • 60. Angioneurotic oedema and urticaria induced by hyoscine butylbromide.
    Robinson AC; Teeling M
    Postgrad Med J; 1982 May; 58(679):316. PubMed ID: 7111123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.